Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

United Therapeutics buy Royal Bank of Canada

United Therapeutics
Start price
€426.90
26.02.26 / 50%
Target price
€544.04
26.02.27
Performance (%)
-0.19%
Price
€426.10
27.02.26
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for United Therapeutics is nearly unchanged. This prediction currently runs until 26.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w
United Therapeutics -0.19%
iShares Core DAX® -0.383%
iShares Nasdaq 100 -0.411%
iShares Nikkei 225® 1.838%
iShares S&P 500 -0.712%

Comments by Royal_Bank_of_Canada for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) -0.19%
Target price 544.042
Change
Ends at 26.02.27

United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $587.00 to $643.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat

Royal Bank of Canada 
0
Report Share
26.02.26

Stopped prediction by Royal_Bank_of_Canada for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€388.80
30.10.25
-
30.10.26
9.59%
27.02.26

Royal Bank of Canada 
30.10.25 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€364.40
26.09.25
€487.63
26.09.26
16.93%
27.02.26

Royal Bank of Canada 
26.09.25 50%